The Food Marketing Institute (FMI) respectfully submits the following comments in response to the Drug Enforcement Administration’s (DEA’s) notice of proposed rulemaking regarding central fill pharmacies. 66 Fed. Reg. 46567 (Sept. 6, 2001). Specifically, under the proposal, DEA would allow central fill facilities to prepare prescriptions for scheduled drugs at the request of and for delivery to retail pharmacies in those states where central fill activities are permitted, provided that certain controls applicable to other pharmacy operations, such as registration and recordkeeping, are established.

Full Comments